Biomea Fusion Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.22

+0.08 (+7.02%)

As of Feb 8, 2:13 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 1 8%

Sell 1 8%

Price Target

Analyst Price Target +131.1% upside

Low Target $1.78

Average Target $2.82

High Target $3.37

Current Price $1.22

Current
$1.22

Target
$2.82

$1.78 $2.82 avg $3.37

Scenario Analysis

Bear Case

$1.78

45.9%

Low target

Base Case

$2.82

+131.1%

Avg target

Bull Case

$3.37

+176.2%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$2.85

-57.2% from high

52-Week Low

$1.78

+-31.5% from low

Target vs 52W High

$2.82

-1.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%